Fingolimod and tumor-infiltrating lymphocytes in checkpoint-inhibitor treated cancer patients

Immune checkpoint inhibitors (ICIs) are emerging as the new standard of care for treating various metastatic cancers. It is known that effective anti-tumor immune responses are associated with a stronger presence of tumor-infiltrating lymphocytes (TILs) in solid tumor tissue. Cancer patients with re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Immunol Immunother
Autors principals: Hasan Ali, Omar, Berner, Fiamma, Ackermann, Christoph Jakob, Ring, Sandra Stephanie, Moulin, Alexandre, Müller, Joachim, Markert, Eva, Pop, Oltin Tiberiu, Müller, Stefanie, Diem, Stefan, Hundsberger, Thomas, Flatz, Lukas
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2020
Matèries:
Research Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7889549/
https://ncbi.nlm.nih.gov/pubmed/32804246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02693-7
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars